drugset / Trial / NCT00564590

SThe Effects of Melatonin on GERD Symptoms

NCT00564590

Phase 1/2 Unknown 150 enrolled Rabin Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We hypothesize that melatonin as compared to PPI and to placebo, improves GERD symptoms by decreasing esophageal acid exposure and esophageal acid sensitivity in GERD. We hypothesize that melatonin as compared to PPI and to placebo reduce the frequency and duration of transient lower esophageal sphincter relaxations (TLESRs). In addition we hypothesize that melatonin as compared to PPI and to placebo improves quality of life and quality of sleep of GERD patients.

Timeline

Start
2008-10
Primary completion
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 4 mg